Cambridge Investment Research Advisors’s Precision BioSciences DTIL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-508	Closed	-$5K	–	3220
2023 Q3	$5K	Hold	508	–	–	﹤0.01%	3122
2023 Q2	$8K	Hold	508	–	–	﹤0.01%	3154
2023 Q1	$11K	Hold	508	–	–	﹤0.01%	3131
2022 Q4	$18K	Sell	508 -33	-6%	-$1.3K	﹤0.01%	3050
2022 Q3	$21K	Buy	541 +33	+6%	+$1.57K	﹤0.01%	3000
2022 Q2	$24K	Sell	508 -10	-2%	-$587	﹤0.01%	2989
2022 Q1	$48K	Buy	+518	New	+$70.4K	﹤0.01%	3079
2021 Q4	–	Sell	-408	Closed	-$141K	–	3200
2021 Q3	$141K	Sell	408 -64	-14%	-$21.7K	﹤0.01%	2895
2021 Q2	$177K	Buy	472 +133	+39%	+$39.9K	﹤0.01%	2867
2021 Q1	$105K	Sell	339 -84	-20%	-$29.4K	﹤0.01%	2751
2020 Q4	$106K	Buy	+423	New	+$104K	﹤0.01%	2591

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Cambridge Investment Research Advisors's DTIL Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Precision BioSciences (DTIL) in Q4 2023, closing a stake of 508 shares — an estimated $5K sold.

Cambridge Investment Research Advisors first reported a position in DTIL in Q4 2020 and held it in 11 quarters. The position peaked at $177K in Q2 2021. 65 funds tracked by Wall St. Rank hold DTIL as of Q4 2023.

Cambridge Investment Research Advisors reported no remaining Precision BioSciences position as of Q4 2023 after selling out during the quarter.
Cambridge Investment Research Advisors sold 508 Precision BioSciences shares in Q4 2023, an estimated $5K.
Cambridge Investment Research Advisors first reported a position in Precision BioSciences in Q4 2020 and held it in 11 quarters.
Cambridge Investment Research Advisors's Precision BioSciences position peaked at $177K in Q2 2021.
65 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.